| 0 (0%) | 08-24 23:56 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 14.57 | 1-year : | 17.02 |
| Resists | First : | 12.47 | Second : | 14.57 |
| Pivot price | 11.17  |
|||
| Supports | First : | 10.37 | Second : | 9.06 |
| MAs | MA(5) : | 12.11 |
MA(20) : | 10.83 |
| MA(100) : | 10.78 |
MA(250) : | 8.38 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 88 |
D(3) : | 89.1 |
| RSI | RSI(14): 60.9 |
|||
| 52-week | High : | 12.96 | Low : | 4.92 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PTEN ] has closed below upper band by 31.4%. Bollinger Bands are 64.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 12.17 - 12.24 | 12.24 - 12.31 |
| Low: | 11.46 - 11.54 | 11.54 - 11.6 |
| Close: | 11.75 - 11.87 | 11.87 - 11.98 |
Mon, 24 Aug 2026
Patterson-UTI Energy Inc (PTEN) Shares Fall 3.8% -- What GF Scor - GuruFocus
Mon, 24 Aug 2026
One gene, many outcomes: Understanding variable cancer risk in PTEN hamartoma tumour syndrome - Wellcome Sanger Institute Blog
Wed, 19 Aug 2026
Is Patterson-UTI (PTEN) Using Its ESOP Shelf To Quietly Reshape Capital Structure And Incentives? - simplywall.st
Sun, 16 Aug 2026
Patterson-UTI Energy (PTEN) Files ESOP Shelf Registration, Is The Stock Still Undervalued? - Yahoo Finance
Fri, 14 Aug 2026
Human Organoids Reveal PTEN-Driven Mesendoderm Specification via Retinoic Acid Signaling Suppression - Science Partner Journals
Thu, 09 Jul 2026
Diagnostic to Identify PTEN Deficiency Launches for Patients With Prostate Cancer - Targeted Oncology
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 381 (M) |
| Shares Float | 374 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 116.3 (%) |
| Shares Short | 30,190 (K) |
| Shares Short P.Month | 30,320 (K) |
| EPS | -0.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.13 |
| Profit Margin | -2 % |
| Operating Margin | -0.6 % |
| Return on Assets (ttm) | -0.6 % |
| Return on Equity (ttm) | -2.8 % |
| Qtrly Rev. Growth | 0.6 % |
| Gross Profit (p.s.) | 2.91 |
| Sales Per Share | 12.24 |
| EBITDA (p.s.) | 2.26 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 733 (M) |
| Levered Free Cash Flow | 274 (M) |
| PE Ratio | -49.42 |
| PEG Ratio | 0.7 |
| Price to Book value | 1.45 |
| Price to Sales | 0.96 |
| Price to Cash Flow | 6.16 |
| Dividend | 0.1 |
| Forward Dividend | 0 |
| Dividend Yield | 0.8% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|